These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8411503)

  • 1. Immunoaugmentative therapy. An unproven cancer treatment.
    Green S
    JAMA; 1993 Oct; 270(14):1719-23. PubMed ID: 8411503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment.
    Pfeifer BL; Jonas WB
    Integr Cancer Ther; 2003 Jun; 2(2):112-9. PubMed ID: 15035898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Questionable methods of cancer management. Immuno-augmentative therapy (IAT).
    CA Cancer J Clin; 1991; 41(6):357-64. PubMed ID: 1933535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic technology assessment. Immunoaugmentative therapy.
    JAMA; 1988 Jun; 259(23):3477-8. PubMed ID: 3373687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoaugmentative therapy. A primer on the perils of unproved treatments.
    Curt GA; Katterhagen G; Mahaney FX
    JAMA; 1986 Jan 24-31; 255(4):505-7. PubMed ID: 3001379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of type-1 innate and acquired immunity in tumor immunotherapy.
    Ikeda H; Chamoto K; Tsuji T; Suzuki Y; Wakita D; Takeshima T; Nishimura T
    Cancer Sci; 2004 Sep; 95(9):697-703. PubMed ID: 15471553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of immune surveillance against tumors. The first theories.
    Ribatti D
    Oncotarget; 2017 Jan; 8(4):7175-7180. PubMed ID: 27764780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment.
    Herbert V
    Cancer; 1986 Oct; 58(8 Suppl):1930-41. PubMed ID: 3756812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Democritus Junior as Reader of Auctoritates: Robert Burton's Method and The Anatomy of Melancholy.
    Mori G
    J Hist Ideas; 2016 Jul; 77(3):379-99. PubMed ID: 27477342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Palliative immunotherapy of cancer].
    Gunsilius E; Clausen J; Gastl G
    Ther Umsch; 2001 Jul; 58(7):419-24. PubMed ID: 11508110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global approach to tumor immunology.
    Wang E; Panelli MC; Monsurró V; Marincola FM
    Cell Mol Immunol; 2004 Aug; 1(4):256-65. PubMed ID: 16225768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.